These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10410827)

  • 21. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
    Schreieck J; Wang Y; Gjini V; Korth M; Zrenner B; Schömig A; Schmitt C
    J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1420-30. PubMed ID: 9436780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
    Cobbe SM; Manley BS
    Cardiovasc Res; 1985 Feb; 19(2):69-75. PubMed ID: 3978667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dofetilide promotes repolarization abnormalities in perfused Guinea-pig heart.
    Osadchii OE
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):489-500. PubMed ID: 22918600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sotalol, aprindine and their combination on maximum upstroke velocity of action potential in guinea-pig papillary muscle.
    Stroobandt R; Kesteloot H
    Eur J Pharmacol; 1986 Nov; 131(2-3):249-56. PubMed ID: 3816955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential recovery of action potential duration and HERG currents from the effects of two methanesulfonamide class III antiarrhythmic agents, KCB-328 and dofetilide.
    Lee K; Park JB; Jeon BH; Kim KJ; Ryu PD; Kwon LS; Kim HY
    J Cardiovasc Pharmacol; 2003 Nov; 42(5):648-55. PubMed ID: 14576514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischemic/reperfused myocardium.
    Rouet R; Picard S; Libersa C; Ghadanfar M; Alabaster C; Gérard JL
    Circulation; 2000 Jan 4-11; 101(1):86-93. PubMed ID: 10618309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
    Hoffmeister HM; Beyer ME; Seipel L
    Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
    Opincariu M; Varró A; Iost N; Virág L; Hála O; Szolnoki J; Szécsi J; Bogáts G; Szenohradszky P; Mátyus P; Papp JG
    Curr Med Chem; 2002 Jan; 9(1):41-6. PubMed ID: 11860346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
    Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
    J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
    Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM
    Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.
    Lynch JJ; Baskin EP; Nutt EM; Guinosso PJ; Hamill T; Salata JJ; Woods CM
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):336-40. PubMed ID: 7752661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes.
    Kiehn J; Villena P; Beyer T; Brachmann J
    J Cardiovasc Pharmacol; 1994 Oct; 24(4):566-72. PubMed ID: 7528839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.
    Knilans TK; Lathrop DA; Nánási PP; Schwartz A; Varró A
    Br J Pharmacol; 1991 Jun; 103(2):1568-72. PubMed ID: 1884111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol.
    Li T; Carr AA; Dage RC
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of d-sotalol on subendocardial Purkinje myocytes isolated from normal or 10 to 14 days postinfarction canine hearts: role of extracellular potassium concentration.
    Marschang H; Schöls W; Karolyi L; Beyer T; Kübler W; Brachmann J
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):274-83. PubMed ID: 9700990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs.
    Kang J; Reynolds WP; Chen XL; Ji J; Wang H; Rampe DE
    Anesthesiology; 2006 May; 104(5):1015-22. PubMed ID: 16645454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes.
    Yang T; Tande PM; Lathrop DA; Refsum H
    Cardiovasc Res; 1992 Nov; 26(11):1109-15. PubMed ID: 1291089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.